Trials / Completed
CompletedNCT04829591
A Multicenter Registry to Study the Characteristics and Outcomes of Jordanian Heart Failure Patients.
The Jordanian Heart Failure Registry (JoHFR)
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 2,219 (actual)
- Sponsor
- Jordan Cardio Vascular Research Group · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
Heart Failure research registry is a collection of computerized information about individuals with heart failure. The database in this registry is obtained from several Jordanian medical centers which will represent an extremely valuable resource for epidemiological research on heart failure patients.
Detailed description
Understanding the cause of Heart Failure (HF) and how the body will respond to it, is critical for an effective treatment. HF is a global problem with significant morbidity and mortality, despite improved understanding of the pathophysiology and a growing range of therapeutic options. Jordanian Heart Failure Registry (JoHFR) will be the first research project of heart failure prevalence in Jordan. It is undertaken by primary healthcare professionals with main aim to improve knowledge about the care of patients with HF. The investigators responsible for conducting this research are physicians and their teams who deal with heart failure patients in their outpatient and inpatient clinic centers including the public and private medical sectors in Jordan's medical community. Standards in the Hashemite kingdom of Jordan complies with the recognized good guideline directed medical practices internationally
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | observational | Heart failure, non interventional |
Timeline
- Start date
- 2021-07-01
- Primary completion
- 2023-12-30
- Completion
- 2023-12-30
- First posted
- 2021-04-02
- Last updated
- 2024-07-19
Locations
1 site across 1 country: Jordan
Source: ClinicalTrials.gov record NCT04829591. Inclusion in this directory is not an endorsement.